These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 7808029

  • 21. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA, Rose AB, Felice MS, Alfaro E, Delfino S, Cygler AM, Sackmann-Muriel F.
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [Abstract] [Full Text] [Related]

  • 22. [Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
    Hirota T, Fujimoto T, Katano N, Tsurasawa M, Eguchi H, Nakadate N, Kamitamari A, Kawakami K, Nishikawa K, Asami K, Shirahata A, Koizumi S, Mugishima H, Gushiken T, Hyakuna N, Imaizumi M, Komatu K, Takitani K, Miyake M, Yanase T.
    Rinsho Ketsueki; 1997 Nov; 38(11):1177-82. PubMed ID: 9423334
    [Abstract] [Full Text] [Related]

  • 23. [Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias].
    Parovichnikova EN, Savchenko VG, Demidova IA, Isaev VG, Shuravina EN, Ustinova EN, Gribanova EO, Aleksanian MZh, Misiurin AV, Domracheva EV, Ol'shanskaia IuV, Khoroshko ND, Kravchenko SK, Konstantinova TS, Anchukova LV, Kaplanov K, Zagoskina TP, Volkova SA, Filatov LB, Rekhtman GB, Sokolova I, Mashuk VN, Miliutina GI, Lapin VA, Perekatova TN, Sviridova EI, Pristupa AS, Ziuzgin IS.
    Ter Arkh; 2004 Nov; 76(7):11-8. PubMed ID: 15379121
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study].
    Parovichnikova EN, Savchenko VG, Kliasova GA, Isaev VG, Demidova IA, Ol'shanskaia IuV, Tiurina NG, Tikhonova LIu, Galstian GM, Pivnik AV.
    Ter Arkh; 1999 Nov; 71(7):20-4. PubMed ID: 10481862
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
    Dai CW, Zhang GS, Shen JK, Zheng WL, Pei MF, Xu YX, Cao YX, Yi Y, Yang JJ, Peng HL, Zhong HY, Li RJ.
    Acta Haematol; 2009 Nov; 121(1):1-8. PubMed ID: 19246888
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).
    Asou N, Adachi K, Tamura U, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama U, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake H, Ohno R.
    Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S65-71. PubMed ID: 11587370
    [Abstract] [Full Text] [Related]

  • 34. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA).
    Wang ZY, Chen Z, Huang W, Li XS, Lu JX, Huang LA, Zhang FQ, Gu LJ, Ouyang RR, Chen SJ.
    Blood Cells; 1993 Aug; 19(3):633-41; discussion 642-7. PubMed ID: 8018944
    [Abstract] [Full Text] [Related]

  • 35. New strategies for the treatment of acute promyelocytic leukaemia.
    Mandelli F.
    J Intern Med Suppl; 1997 Aug; 740():23-7. PubMed ID: 9350178
    [Abstract] [Full Text] [Related]

  • 36. Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80.
    Takeuchi M, Yano T, Omoto E, Takahashi K, Kibata M, Shudo K, Harada M, Ueda R, Ohno R.
    Leuk Lymphoma; 1998 Nov; 31(5-6):441-51. PubMed ID: 9922035
    [Abstract] [Full Text] [Related]

  • 37. Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.
    Finsinger P, Breccia M, Minotti C, Carmosino I, Girmenia C, Chisini M, Volpicelli P, Vozella F, Romano A, Montagna C, Colafigli G, Cimino G, Avvisati G, Petti MC, Lo-Coco F, Foà R, Latagliata R.
    Ann Hematol; 2015 Feb; 94(2):195-200. PubMed ID: 25186786
    [Abstract] [Full Text] [Related]

  • 38. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
    Visani G, Zauli G, Tosi P, Ottaviani E, Gibellini D, Manfroi S, Celeghini C, Pagliarini C, Bassini A, Tura S.
    Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
    [Abstract] [Full Text] [Related]

  • 39. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group.
    Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D.
    Blood; 1993 Dec 01; 82(11):3241-9. PubMed ID: 8241496
    [Abstract] [Full Text] [Related]

  • 40. Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.
    Estey E, Thall PF, Pierce S, Kantarjian H, Keating M.
    J Clin Oncol; 1997 Feb 01; 15(2):483-90. PubMed ID: 9053469
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.